CLEC16A and myeloid sarcoma: Furthermore, a deeper understanding of CLEC16A's role in MS susceptibility could provide valuable insights into the underlying immune dysregulation and inform potential therapeutic targets for treatments aimed at modulating immune responses and mitigating disease progression.